The NYU team systematically identified 46 key long-chain non-coding RNAs (e.g., MALAT1, MIR17HG) that regulate cancer progression through transcriptome-scale CRISPR-Cas13 screening, in which knockdown of MALAT1 inhibits tumor metastasis, while the regulation of MIR17HG affects cell cycle progression (Liang et al., 2024). This evidence concerns the gene MIR17HG and neoplasm.